Z-0323-2024 Class II Ongoing

Recalled by Musculoskeletal Transplant Foundation, Inc. — Edison, NJ

FDA device recall Z-0323-2024 was initiated by Musculoskeletal Transplant Foundation, Inc. on Sep 22, 2023 and is designated Class II. Reason for recall: Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery. The recall status is ongoing. Affected quantity: 18 units.

Recall details

Product Type
Devices
Report Date
Nov 29, 2023
Initiation Date
Sep 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18 units

Product description

DBX Demineralized Bone Matrix Putty 10cc-Indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. Model Number: 038100

Reason for recall

Units are labeled as 10cc; however the units have a fill volume of 1cc units. This may result in prolongation of surgery.

Distribution pattern

US Nationwide distribution in the states of PA, TX, WA.

Code information

GUID: W4184038100T0473 Serial #s: 002220854711400006 002220854711400056 002220854711400003 002220854711400008 002220854711400009 002220854711400001 002220854711400002 002220854711400010 002220854711400011 002220854711400012 002220854711400013 002220854711400014 002220854711400004 002220854711400005 002220854711400007 Exp.Date: June 20, 2025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0323-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0323-2024. Report a data issue: hello@regdatalab.com.